Showing results (621-630 of 3,096) with videos related to
Sort By:
Pageof 310
Expert Review of Anticancer Therapy|October 16, 2009
Molecular changes in pancreatic cancerMalte Buchholz, Thomas M GressExpert Review of Anticancer Therapy|April 21, 2017
Metastatic soft tissue sarcoma: current treatment landscape and future perspectivesE Skafida, S Kokkali, M Nikolaou, et al.Expert Review of Anticancer Therapy|April 16, 2020
Evolution in the management of soft tissue sarcoma: classification, surgery and use of radiotherapyAngelo Paolo Dei Tos, Sylvie Bonvalot, Rick HaasExpert Review of Anticancer Therapy|April 16, 2020
Avelumab and axitinib in the treatment of renal cell carcinoma: safety and efficacyIsla Leslie, Laura Amanda Boos, James Larkin, et al.Expert Review of Anticancer Therapy|April 18, 2020
EGFR mutation-positive NSCLC: factors to consider when deciding first-line therapyPauline Hulo, Dahna Coupez, Marc G Denis, et al.Expert Review of Anticancer Therapy|April 17, 2020
Pexidartinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor: safety and efficacyEmanuela Palmerini, Alessandra Longhi, Davide Maria Donati, et al.Expert Review of Anticancer Therapy|May 12, 2015
When crizotinib-induced bradycardia becomes symptomatic: role of concomitant drugsGiuseppina Gallucci, Alfredo Tartarone, Lucia Lombardi, et al.Expert Review of Anticancer Therapy|April 15, 2021
How can we turn the PI3K/AKT/mTOR pathway down? Insights into inhibition and treatment of cancerSaid M Afify, Aung Ko Ko Oo, Ghmkin Hassan, et al.Expert Review of Anticancer Therapy|July 1, 2020
Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studiesTobias Sprenger, Volker Schirrmacher, Wilfried Stücker, et al.Expert Review of Anticancer Therapy|February 8, 2026
Integrating liquid biopsies in non-small cell lung cancer diagnosis and management: opportunities and challengesJeong Uk Lim, Yuko Oya, Rui Fu, et al.Pageof 310